Pattern Separation in Major Depressive Disorder (NCT07139834) | Clinical Trial Compass
RecruitingPhase 1
Pattern Separation in Major Depressive Disorder
United States30 participantsStarted 2026-06-01
Plain-language summary
This study seeks to examine the effects of treatment with a selective serotonin reuptake inhibitor (SSRI), escitalopram, a first-line treatment for depression, in combination with placebo or with extended-release memantine, on neuropsychological function, regional brain activity assessed by functional magnetic resonance imaging, and depressive symptoms, in participants with Major Depressive Disorder. Escitalopram is administered in an open-label fashion in this study; extended release memantine is administered in a double-blind, randomized, placebo-controlled manner.
Who can participate
Age range
18 Years – 50 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age 18-50
* Current diagnosis of MDD without psychotic features assessed within three weeks of study enrollment
* 17-item Hamilton Depression Rating Scale score ≥17 assessed within 3 weeks of study enrollment
* Using an effective form of contraception at study enrollment and agrees to continue throughout study participation for individuals of child-bearing potential
* Capacity to provide informed consent
* Proficient in English
* Willing to provide emergency contact
Exclusion Criteria:
* Currently taking an antidepressant medication at study enrollment
* Pregnant or breastfeeding at time of enrollment
* Evidence of current unstable medical illness, including liver or renal impairment, or unstable cardiovascular or respiratory illness
* QTc interval greater than 500 ms
* Current genitourinary conditions that raise urine pH such as a) renal tubular acidosis or b) severe infection of the urinary tract.
* Clinically significant neurological conditions, including a) history of stroke, b) previous head injury with evidence of cognitive impairment, c) history of malignancy or d) history of seizure disorder. (headache, migraines, pain disorders, and other conditions not exclusionary)
* Lifetime diagnosis of a) bipolar disorder, b) psychotic disorder, or c) dementia
* Current active suicidal ideation
* Current substance use disorder other than tobacco use disorder
* Current or recent (past 6 months) treatment with antipsychotics; current or recent (past 1 mont…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Pattern Separation Performance
Timeframe: At baseline (week 0) and after completing the medication trial (week 11)